News

Digital illustration of a virus

PRiME announces a COVID-19 Task Force on Advanced Diagnostics and New Therapeutics

Article from https://www.prime.utoronto.ca/news As the global community responds to the COVID-19 pandemic, PRiME is convening its leading researchers to form a COVID-19 Task Force on Advanced Diagnostics and New Therapeutics to develop an arsenal of breakthroughs to fight COVID-19 and future pandemics. UofT researchers who are leading experts in disease biology, medicinal chemistry, device engineering, […]
Photo of Shaf Keshavjee from Medicine by Design

Medicine by Design announces four new team projects

Medicine by Design is expanding its regenerative medicine research portfolio with the addition of four multi-disciplinary, multi-institution projects that will lead to advances in the understanding and treatment of cardiovascular and lung diseases, diabetes and neurological disorders.

Researchers from U of T, affiliated hospitals form research consortium to study risks and benefits of cannabis

The Toronto Cannabis and Cannabinoid Research Consortium (TC3) was launched Thursday at a conference of researchers, government officials, policy-makers and industry representatives. TC3 combines the research muscle of the university with a dozen academic hospitals. “There is a huge research engine at U of T,” said Ruth Ross, a professor and chair of the Faculty of Medicine’s pharmacology and toxicology department and a member of the TC3 steering committee.

Cannabis Innovation Summit to officially launch U of T-led research consortium

Researchers from UofT and its affiliated hospitals will meet this week at the Cannabis Innovation Summit to launch TC3 (Toronto Cannabis and Cannabinoid Research Consortium — a partnership focused on the health effects of cannabis and related compounds.
What are you searching for today?
magnifiercrosschevron-down